CoChat
Sign Up
Cited by 104

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

TOXICITY OF CHEMOTHERAPY

Lowenthal, Raymond M., Eaton, Kristine·1996·Hematology/Oncology Clinics of North America
DOI 10.1016/s0889-8588(05)70378-6
Open this paper in CoChat — free account

Abstract

Because anticancer drugs are cytotoxic for normal as well as neoplastic cells, the range of unwanted effects that accompanies their use is broad. Many of the side effects are potentially life-threatening or seriously debilitating. Many are similar to, and readily confused with, direct or indirect (paraneoplastic) consequences of the cancer itself. Recognition of drug side effects is vital for optimal patient care, because early withdrawal of the offending agent and institution of appropriate treatment have the potential to significantly reduce the overall morbidity and mortality associated with the diagnosis of cancer.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0889-8588(05)70378-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 140

  1. Alexander, 1979, Serial assessment of doxorubicin cardiotoxic-ity with quantitative radionuclide angiocardiography, N Engl J Med, 300, 278, 10.1056/NEJM197902083000603 · DOI
  2. Andersson, 1985, Subacute pulmonary failure complicating therapy with high dose Ara-C in acute leukemia, Cancer, 56, 2181, 10.1002/1097-0142(19851101)56:9<2181::AID-CNCR2820560907>3.0.CO;2-B · DOI
  3. Aristizabal, 1977, Complications from combination chemotherapy and irradiation in oat cell lung cancer [letter], JAMA, 237, 1824, 10.1001/jama.1977.03270440014004 · DOI
  4. Bannwarth, 1994, Methotrexate in rheumatoid arthritis. An update, Drugs, 47, 25, 10.2165/00003495-199447010-00003 · DOI
  5. Barton, 1990, Effects of chemotherapy on fertility, Blood Rev, 4, 187, 10.1016/0268-960X(90)90047-V · DOI
  6. Bishop JF, Matthews JP, Young GA, et al: A randomized study of high dose cytarabine in induction in acute myeloid leukemia. Blood, in press
  7. Biti, 1994, Second solid tumors and leukemia after treatment for Hodgkin's disease: Analysis of 1121 patients from a single institution, Int J Radiat Oncol Biol Phys, 29, 25, 10.1016/0360-3016(94)90222-4 · DOI
  8. Blaney, 1991, Current pharmacological treatment approaches to central nervous system leukaemia, Drugs, 41, 702, 10.2165/00003495-199141050-00003 · DOI
  9. Blankenship, 1983, Drugs and alopecia, Australas J Dermatol, 24, 100, 10.1111/j.1440-0960.1983.tb00264.x · DOI
  10. Blatt, 1980, Pregnancy outcome following cancer chemotherapy, Am J Med, 69, 828, 10.1016/S0002-9343(80)80007-6 · DOI
  11. Bleyer, 1973, Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia, N Engl J Med, 289, 770, 10.1056/NEJM197310112891503 · DOI
  12. Blum, 1973, A clinical review of bleomycin--a new antineoplastic agent, Cancer, 31, 903, 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N · DOI
  13. Borison, 1953, Physiology and pharmacology of vomiting, Pharmacol Rev, 5, 193, 10.1016/S0031-6997(25)07328-4 · DOI
  14. Buchanan, 1984, Drug-induced infertility, Drug Intelligence and Clinical Pharmacy, 18, 122, 10.1177/106002808401800205 · DOI
  15. Burns, 1992, Ocular toxicities of chemotherapy, Semin Oncol, 19, 492
  16. Buzdar, 1980, Pulmonary toxicity of mitomycin, Cancer, 45, 236, 10.1002/1097-0142(19800115)45:2<236::AID-CNCR2820450207>3.0.CO;2-0 · DOI
  17. Calvert, 1988, Carboplatin or cisplatin?, Lancet, 2, 577, 10.1016/S0140-6736(88)92709-2 · DOI
  18. Canellos, 1992, Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD, N Engl J Med, 327, 1478, 10.1056/NEJM199211193272102 · DOI
  19. Carson, 1987, Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate, Semin Arthritis Rheum, 16, 186, 10.1016/0049-0172(87)90021-7 · DOI
  20. Chapman, 1982, Effect of cytotoxic therapy on sexuality and gonadal function, Semin Oncol, 9, 84
  21. Chapman, 1979, Cytotoxic-induced ovarian failure in women with Hodgkin's disease. 1. Hormone function, JAMA, 242, 1877, 10.1001/jama.1979.03300170023020 · DOI
  22. Chapman, 1981, Male gonadal dysfunction in Hodgkin's disease. A prospective study, JAMA, 245, 1323, 10.1001/jama.1981.03310380027020 · DOI
  23. Chapman, 1979, Cyclical combination chemotherapy and gonadal dysfunction. Retrospective study in males, Lancet, 1, 285, 10.1016/S0140-6736(79)90701-3 · DOI
  24. Cohen, 1980, Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma, Am J Med, 68, 486, 10.1016/0002-9343(80)90286-7 · DOI
  25. Cooper, 1986, Drug induced pulmonary disease: Part 1: Cytotoxic drugs, Am Rev Respir Dis, 133, 321
  26. Crawford, 1991, Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer, N Engl J Med, 325, 164, 10.1056/NEJM199107183250305 · DOI
  27. Crounse, 1960, Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs, J Invest Dermatol, 35, 83, 10.1038/jid.1960.88 · DOI
  28. Cubeddu, 1992, Mechanisms by which cancer chemotherapeutic drugs induce emesis, Sernin Oncol, 19, 2
  29. Curran, 1989, Ocular adverse reactions associated with Adriamycin (doxorubi-cin), Am J Ophthalmol, 108, 709, 10.1016/0002-9394(89)90866-0 · DOI
  30. D'Angio, 1959, Potentiation of x-ray effects by actinomycin D, Radiology, 73, 175, 10.1148/73.2.175 · DOI
  31. Daugaard, 1988, Renal tubular function in patients treated with high-dose cisplatin, Clin Pharmacol Ther, 44, 164, 10.1038/clpt.1988.132 · DOI
  32. DeFronzo, 1974, Cyclophosphamide and the kidney, Cancer, 33, 483, 10.1002/1097-0142(197402)33:2<483::AID-CNCR2820330224>3.0.CO;2-P · DOI
  33. DeSpain, 1992, Dermatologic toxicity of chemotherapy, Semin Oncol, 19, 501
  34. Doll, 1985, Mitomycin: Ten years after approval for marketing, J Clin Oncol, 3, 276, 10.1200/JCO.1985.3.2.276 · DOI
  35. Doroshow, 1981, Ocular irritation from high-dose methotrexate therapy: Pharmacokinetics of drug in the tear film, Cancer, 48, 2158, 10.1002/1097-0142(19811115)48:10<2158::AID-CNCR2820481007>3.0.CO;2-I · DOI
  36. Dunagin, 1982, Clinical toxicity of chemotherapeutic agents: Dermatologic toxicity, Semin Oncol, 9, 14
  37. Durant, 1979, Pulmonary toxicity associated with bischlor-ethylnitrosourea (BCNU), Ann Intern Med, 90, 191, 10.7326/0003-4819-90-2-191 · DOI
  38. Etcubanas, 1974, Uncommon side effects of Adriamycin (NSC-123127), Cancer Chemother Rep, 58, 757
  39. Eyster, 1967, Melphalan (Alkeran) erythrocyte agglutinin and hemolytic anemia, Ann Intern Med, 66, 573, 10.7326/0003-4819-66-3-573 · DOI
  40. Fairley, 1972, Sterility and testicular atrophy related to cyclophos-phamide therapy, Lancet, 1, 568, 10.1016/S0140-6736(72)90358-3 · DOI
  41. Gauci, 1980, Changes in hair pigmentation associated with cancer chemotherapy [letter], Cancer Treat Rep, 64, 193
  42. Getaz, 1980, Cisplatin-induced hemolysis, N Engl J Med, 302, 334, 10.1056/NEJM198002073020607 · DOI
  43. Ginsberg, 1982, The pulmonary toxicity of antineoplastic agents, Semin Oncol, 9, 34
  44. Goldberg, 1986, Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor, Blood, 68, 1114, 10.1182/blood.V68.5.1114.1114 · DOI
  45. Goldiner, 1978, Factors influencing postoperative morbidity and mortality in patients treated with bleomycin, Br Med J, 1, t664, 10.1136/bmj.1.6128.1664 · DOI
  46. Gonzalez-Vitale, 1978, Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies, Cancer Treat Rep, 62, 693
  47. Goodman, 1946, Nitrogen mustard therapy: Use of methylbis (B-chloroethyl) amino hydrochloride for Hodgkin's disease, lymphosar-coma, leukemia and certain allied and miscellaneous disorders, JAMA, 132, 126, 10.1001/jama.1946.02870380008004 · DOI
  48. Goorin, 1990, Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer, J Pediatr, 116, 144, 10.1016/S0022-3476(05)81668-3 · DOI
  49. Green, 1988, Severe reversible interstitial pneumonitis induced by low dose methotrexate: Report of a case and review of the literature, J Rheumatol, 15, 110
  50. Greenbaum, 1959, Dangers of uric acid excretion during treatment of leukaemia and lymphoma, Lancet, 1, 73, 10.1016/S0140-6736(59)91140-7 · DOI
  51. Greene, 1986, Melphalan may be a more potent leukemogen than cyclophosphamide, Ann Intern Med, 105, 360, 10.7326/0003-4819-105-3-360 · DOI
  52. Griffin, 1981, Eye toxicity of cancer chemotherapy: A review of the literature, Cancer, 48, 1539, 10.1002/1097-0142(19811001)48:7<1539::AID-CNCR2820480713>3.0.CO;2-B · DOI
  53. Grunberg, 1990, Control of chemotherapy-induced emesis, N Engl J Med, 329, 1790
  54. Gunstream, 1983, Mitomycin-associated lung disease, Cancer Treat Rep, 67, 301
  55. Heard, 1968, Busulphan lung, Thorax, 23, 187, 10.1136/thx.23.2.187 · DOI
  56. Hood, 1986, Cutaneous side effects of cancer chemotherapy, Med Clin North Am, 70, 187, 10.1016/S0025-7125(16)30976-2 · DOI
  57. Horton, 1970, 5-fluorouracil in cancer: An improved regimen, Ann Intern Med, 73, 897, 10.7326/0003-4819-73-6-897 · DOI
  58. Hoyle, 1989, AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: Results from the MRC's 9th AML trial, Br J Haematol, 72, 45, 10.1111/j.1365-2141.1989.tb07650.x · DOI
  59. Ignoffo, 1980, Therapy of local toxicities caused by extravasation of cancer chemotherapeutic agents, Cancer Treat Rev, 7, 17, 10.1016/S0305-7372(80)80023-5 · DOI
  60. Jones, 1989, Anthracycline-induced toxicity affecting palmar and plantar skin, Br J Cancer, 59, 814, 10.1038/bjc.1989.170 · DOI
  61. Kaldor, 1990, Leukemia following Hodgkin's disease, N Engl J Med, 322, 7, 10.1056/NEJM199001043220102 · DOI
  62. Kaldor, 1990, Leukemia following chemotherapy for ovarian cancer, N Engl J Med, 322, 1, 10.1056/NEJM199001043220101 · DOI
  63. Kay, 1992, 2-chlorodeoxyadenosine treatment of low-grade lymphomas, J Clin Oncol, 10, 371, 10.1200/JCO.1992.10.3.371 · DOI
  64. Khansur, 1991, Case reports. Cisplatin-induced hemolytic uremic syndrome, Am J Med Sci, 301, 390, 10.1097/00000441-199106000-00006 · DOI
  65. Kleiman, 1987, Prinzmetal's angina during 5-fiuorouracil chemotherapy, Am J Med, 82, 566, 10.1016/0002-9343(87)90465-7 · DOI
  66. Kreisman, 1992, Pulmonary toxicity of antineoplastic therapy, Semin Oncol, 19, 508
  67. Kreuser, 1990, Gonadal toxicity following cancer therapy in adults: Significance, diagnosis, prevention and treatment, Cancer Treat Rev, 17, 169, 10.1016/0305-7372(90)90043-F · DOI
  68. Kris, 1985, Incidence, course, and severity of delayed nausea and vomiting following the administration of high dose cisplatin, J Clin Oncol, 3, 1379, 10.1200/JCO.1985.3.10.1379 · DOI
  69. Land, 1972, Toxicity of L-asparaginase in children with advanced leukemia, Cancer, 30, 339, 10.1002/1097-0142(197208)30:2<339::AID-CNCR2820300206>3.0.CO;2-P · DOI
  70. Lehne, 1990, Pulmonary toxicity of cytotoxic and immunosuppressive agents: A review, Acta Oncol, 29, 113, 10.3109/02841869009126530 · DOI
  71. Lentz, 1977, Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty, J Pediatr, 91, 385, 10.1016/S0022-3476(77)81305-X · DOI
  72. Levitt, 1972, Combination sequential chemotherapy in advanced reticulum cell sarcoma, Cancer, 29, 630, 10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q · DOI
  73. Lipshultz, 1991, Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia M childhood, N Engl J Med, 324, 808, 10.1056/NEJM199103213241205 · DOI
  74. Lorenz, 1977, Histamine release in dogs by Cremophor E1 and its derivatives: Oxethylated oleic acid is the most effective constituent, Agents Actions, 7, 63, 10.1007/BF01964882 · DOI
  75. Lowenthal, 1993, Transfusion-associated graft-versus-host disease: Report of an occurrence following the administration of irradiated blood, Transfusion, 33, 524, 10.1046/j.1537-2995.1993.33693296818.x · DOI
  76. Madias, 1978, Platinum nephrotoxicity, Am J Med, 65, 307, 10.1016/0002-9343(78)90825-2 · DOI
  77. Maiche, 1988, Renal insufficiency in patients treated with high dose methotrexate, Acta Oncol, 27, 73, 10.3109/02841868809090322 · DOI
  78. McDonald, 1993, Veno-occlusive disease of the liver and multiorgan failure after BM transplantation: A cohort study of 355 patients, Ann Intern Med, 118, 255, 10.7326/0003-4819-118-4-199302150-00003 · DOI
  79. McGuire, 1989, Taxol: A unique anti-neoplastic agent with significant activity in advanced ovarian epithelial neoplasms, Ann Intern Med, 111, 273, 10.7326/0003-4819-111-4-273 · DOI
  80. Mcintosh, 1977, Methotrexate hepatotoxicity in children with leukemia, J Pediatr, 90, 1019, 10.1016/S0022-3476(77)80587-8 · DOI
  81. Middleton, 1985, Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine, Cancer Treat Rep, 69, 373
  82. Miller, 1971, Alkylating agents and human spermatogenesis, JAMA, 217, 1662, 10.1001/jama.1971.03190120030006 · DOI
  83. Mitchell, 1982, Gastrointestinal toxicity of chemotherapeutic agents, Semin Oncol, 9, 52
  84. Mitchell, 1992, Gastrointestinal toxicity of chemotherapeutic agents, Semin Oncol, 19, 566
  85. Moormeier, 1990, High dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignancies, J Natl Cancer Inst, 82, 29, 10.1093/jnci/82.1.29 · DOI
  86. Morrow, 1982, Behavioral treatment for anticipatory nausea and vomiting induced by cancer chemotherapy, N Engl J Med, 307, 1476, 10.1056/NEJM198212093072402 · DOI
  87. Muggia, 1983, Pulmonary toxicity of antitumor agents, Cancer Treat Rev, 10, 221, 10.1016/0305-7372(83)90012-9 · DOI
  88. Myers, 1992, Prospects for fertility after cancer chemotherapy, Semin Oncol, 19, 597
  89. Newbury-Ecob, 1989, Ifosfamide-induced Fanconi syndrome [letter], Lancet, 1, 1328, 10.1016/S0140-6736(89)92719-0 · DOI
  90. Nixon, 1976, Alterations in nail pigment with cancer chemotherapy, Arch Intern Med, 136, 1117, 10.1001/archinte.1976.03630100029009 · DOI
  91. Oksenhendler, 1989, Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia, Eur J Cancer Clin Oncol, 25, 1181, 10.1016/0277-5379(89)90412-4 · DOI
  92. Patel, 1976, Cyclophosphamide therapy and interstitial pulmonary fibrosis, Cancer, 38, 1542, 10.1002/1097-0142(197610)38:4<1542::AID-CNCR2820380416>3.0.CO;2-R · DOI
  93. Patterson, 1992, Renal toxicities of chemotherapy, Semin Oncol, 19, 521
  94. Pavy, 1982, Hemolytic-uremic syndrome associated with mito-mycin therapy, Cancer Treat Rep, 66, 457
  95. Pedersen-Bjergaard, 1987, Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkyl-ating agents, and time from chemotherapy, Lancet, 2, 83, 10.1016/S0140-6736(87)92744-9 · DOI
  96. Perks, 1992, Cancer chemotherapy and fertility [letter], Br Med J, 305, 51, 10.1136/bmj.305.6844.51-a · DOI
  97. Peterson, 1992, Oral toxicity of chemotherapeutic agents, Semin Oncol, 19, 478
  98. Phillips, 1983, Intensive 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer, Cancer, 52, 1792, 10.1002/1097-0142(19831115)52:10<1792::AID-CNCR2820521006>3.0.CO;2-D · DOI
  99. Pui, 1991, Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia, N Engl J Med, 325, 1682, 10.1056/NEJM199112123252402 · DOI
  100. Richter, 1970, Effect of chlorambucil on spermatogen-esis in the human with malignant lymphoma, Cancer, 25, 1026, 10.1002/1097-0142(197005)25:5<1026::AID-CNCR2820250506>3.0.CO;2-C · DOI
  101. Rieselbach, 1964, Uric acid excretion and renal function in the acute hyperuricemia of leukemia, Am J Med, 37, 872, 10.1016/0002-9343(64)90130-5 · DOI
  102. Pitch, 1983, Ocular toxicity from high dose cytosine arabinoside, Cancer, 51, 430, 10.1002/1097-0142(19830201)51:3<430::AID-CNCR2820510313>3.0.CO;2-5 · DOI
  103. Robinson, 1994, Second malignant neoplasms in patients with Hodgkin's disease, Aust NZ J Med, 24, 368, 10.1111/j.1445-5994.1994.tb01463.x · DOI
  104. Roeser, 1978, Testicular damage due to cytotoxic drugs and recovery after cessation of therapy, Aust NZ J Med, 8, 250, 10.1111/j.1445-5994.1978.tb04518.x · DOI
  105. Rosenow, 1992, Drug-induced pulmonary disease. An update, Chest, 102, 239, 10.1378/chest.102.1.239 · DOI
  106. Rosenthal, 1974, Vincristine neurotoxicity, Ann Intern Med, 80, 733, 10.7326/0003-4819-80-6-733 · DOI
  107. Rowinsky, 1995, Paclitaxel (Taxol), N Engl J Med, 332, 1004, 10.1056/NEJM199504133321507 · DOI · Paper page
  108. Sandvei, 1987, Fluorouracil (5-FU) induced acute immune haemolytic anaemia, Br J Haematol, 65, 357, 10.1111/j.1365-2141.1987.tb06868.x · DOI
  109. Schein, 1975, Immunosuppressive and cytotoxic chemotherapy: Long-term complications, Ann Intern Med, 82, 84, 10.7326/0003-4819-82-1-84 · DOI
  110. Schilsky, 1982, Renal and metabolic toxicities of cancer chemotherapy, Semin Oncol, 9, 75
  111. Schilsky, 1980, Gonadal dysfunction in patients receiving chemotherapy for cancer, Ann Intern Med, 93, 109, 10.7326/0003-4819-93-1-109 · DOI
  112. Schilsky, 1981, Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease, Am J Med, 71, 552, 10.1016/0002-9343(81)90205-9 · DOI
  113. Searles, 1987, Methotrexate pneumonitis in rheumatoid arthritis: Potential risk factors. Four case reports and a review of the literature, J Rheumatol, 14, 1164
  114. Sears, 1964, Erythema in areas of previous irradiation in patients treated with hydroxy-urea (NSC-32065), Cancer Chemother Rep, 40, 31
  115. Selker, 1980, 1,3-Bis(2-chloroethyl)-l-nitrosourea (BCNU)-induced pulmonary fibrosis, Neurosurgery, 7, 560, 10.1227/00006123-198012000-00003 · DOI
  116. Shall, 1988, Painful red hands: A side effect of leukaemia therapy, Br J Dermatol, 119, 249, 10.1111/j.1365-2133.1988.tb03208.x · DOI
  117. Sheridan, 1989, Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous BM transplantation, Lancet, 2, 891, 10.1016/S0140-6736(89)91552-3 · DOI
  118. Siimes, 1990, Small testicles with impaired production of sperm in adult male survivors of childhood malignancies, Cancer, 65, 1303, 10.1002/1097-0142(19900315)65:6<1303::AID-CNCR2820650608>3.0.CO;2-D · DOI
  119. Speyer, 1992, ICRF-187 permits longer treatment with doxorubicin in women with breast cancer, J Clin Oncol, 10, 117, 10.1200/JCO.1992.10.1.117 · DOI
  120. Spitz, 1948, The histological effects of nitrogen mustards on human tumors and tissues, Cancer, 1, 383, 10.1002/1097-0142(194809)1:3<383::AID-CNCR2820010304>3.0.CO;2-0 · DOI
  121. Steinberg, 1985, Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity, Clin Ther, 7, 660
  122. Steinberg, 1987, Acute arrhythmogenicity of doxorubi-cin administration, Cancer, 60, 1213, 10.1002/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V · DOI
  123. Swerdlow, 1992, Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation, Br Med J, 304, 1137, 10.1136/bmj.304.6835.1137 · DOI
  124. Taetle, 1978, Pulmonary histopathologic changes associated with melphalan therapy, Cancer, 42, 1239, 10.1002/1097-0142(197809)42:3<1239::AID-CNCR2820420332>3.0.CO;2-I · DOI
  125. Takvorian, 1983, Autologous BM transplantation: Host effects of high dose BCNU, J Clin Oncol, 1, 610, 10.1200/JCO.1983.1.10.610 · DOI
  126. Tortorice, 1990, Management of chemotherapy-induced nausea and vomiting, Pharmacotherapy, 10, 129, 10.1002/j.1875-9114.1990.tb02560.x · DOI
  127. Travis, 1994, Risk of leukemia following treatment for non-Hodgkin's lymphoma, J Natl Cancer Inst, 86, 1450, 10.1093/jnci/86.19.1450 · DOI
  128. van Leeuwen, 1994, Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and BM damage, J Clin Oncol, 12, 1063, 10.1200/JCO.1994.12.5.1063 · DOI
  129. Verschoore, 1987, Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer, Radiother Oncol, 9, 281, 10.1016/S0167-8140(87)80149-4 · DOI
  130. Verwey, 1987, Mitomycin C-induced renal toxicity, a dose dependent side effect?, Eur J Cancer Clin Oncol, 23, 195, 10.1016/0277-5379(87)90014-9 · DOI
  131. Von Hoff, 1979, Risk factors for doxorubicin-induced congestive heart failure, Ann Intern Med, 91, 710, 10.7326/0003-4819-91-5-710 · DOI
  132. Von Hoff, 1979, Toxic effects of cis-dichlorodiammi-neplatinum (II) in man, Cancer Treat Rep, 63, 1527
  133. Wallace, 1989, Gonadal dysfunction due to cis-platinum, Med Pediatr Oncol, 17, 409, 10.1002/mpo.2950170510 · DOI
  134. Wame, 1973, Cyclophosphamide-induced ovarian failure, N Engl J Med, 289, 1159, 10.1056/NEJM197311292892202 · DOI
  135. Waxman, 1985, Cancer, chemotherapy and fertility [editorial], Br Med J, 290, 1096, 10.1136/bmj.290.6475.1096 · DOI
  136. Weick, 1992, A randomized investigation of high dose versus standard dose cytosine arabinoside with daunorubicin in patients with acute myelogenous leukemia [abstract], Proc Am Soc Clin Oncol, 11, 261
  137. Weiss, 1974, Neurotoxicity of commonly used antineoplastic agents, N Engl J Med, 291, 127, 10.1056/NEJM197407182910305 · DOI
  138. Weiss, 1986, Amsacrine-associated cardiotoxicity: An analysis of 82 cases, J Clin Oncol, 4, 918, 10.1200/JCO.1986.4.6.918 · DOI
  139. White, 1984, Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids, Chest, 86, 723, 10.1378/chest.86.5.723 · DOI
  140. Young, 1994, Adverse drug reactions. Cytotoxic-induced nail pigmentation, Current Therapeutics, 35, 31

Cited by

Sorted by citations

See all 104

Metadata

Authors
Lowenthal, R. M., & Eaton, K.
Venue
Hematology/Oncology Clinics of North America
Publisher
Elsevier BV
Published
1996-08
Volume
10
Issue
4
Pages
967-990
ISSN
0889-8588
DOI
10.1016/s0889-8588(05)70378-6
Cited by
104
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review